Patent · US Active

Manufacture of a triiodinated contrast agent

US8835672B2 · kind B2 · utility

0Cited by
3References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 2012
Grant dateSep 16, 2014
Priority date
Expiry dateFeb 2, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C235/16
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A new compound, (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid, of formula II (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid. Said new compound is of use for the production of triiodinated contrast agent, especially lopamidol, with low content of acetyl and hydroxyacetyl analogs. The new compound may be formed from 5-amino-2,4,6-triiodoisophtalic acid by acylating with (S)-1-chloro-1-oxopropan-2-yl acetate. The new compound may then be converted to the respective acid dichloride by reacting with a chlorinating reagent, which is a further object of the present invention, followed by the amidation with 2-amino-1,3-propanediol and acetate hydrolysis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.